Patent details
EP2286818 Title: Fulvestrant formulation
Basic Information
- Publication number:
- EP2286818
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Expired
- Application number:
- EP101806610
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Fulvestrant formulation
- French Title of Invention:
- Formulation de fulvestrant
- German Title of Invention:
- Fulvestrant Formulierung
- SPC Number:
Dates
- Filing date:
- 08/01/2001
- Grant date:
- 18/03/2020
- EP Publication Date:
- 23/02/2011
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 18/03/2020
- EP B1 Publication Date:
- 18/03/2020
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 08/01/2021
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 11/03/2020
- Name:
- AstraZeneca AB
- Address:
- Forskargatan 18, 151 85 Södertälje, Sweden (SE)
Inventor
1
- Name:
- Evans, John
- Address:
- United Kingdom (GB)
2
- Name:
- Grundy, Rosalind, Ursula
- Address:
- United Kingdom (GB)
Priority
1
- Priority Number:
- 0000313
- Priority Date:
- 10/01/2000
- Priority Country:
- United Kingdom (GB)
2
- Priority Number:
- 0008837
- Priority Date:
- 12/04/2000
- Priority Country:
- United Kingdom (GB)
Classification
- IPC classification:
- A61K 9/08; A61K 31/565; A61P 35/00; A61K 47/14; A61K 47/44;
Publication
European Patent Bulletin
- Issue number:
- 202012
- Publication date:
- 18/03/2020
- Description:
- Grant (B1)
| Filing date | Document type | Number of pages |
|---|